In Brief: SmithKline Beecham
This article was originally published in The Tan Sheet
Executive Summary
SmithKline Beecham: Signs agreement with Penederm to market several undisclosed products in Eastern and Western Europe and the Middle East using Penederm's TopiCare Delivery Compounds. The companies are projecting that marketing will begin by the start of the fourth quarter. Penederm describes its TopiCare product as "patented polymers that improve the effects or delivery of the active ingredients" in OTC, prescription and cosmetic products...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning